免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

PubMed

Grave fraudulence in medical device research: a narrative review of the PIN seeding study for the Pinnacle hip system.

PMID: 29258356 · 2018

J, o, a, n, , E, , S, t, e, f, f, e, n, ;, , E, l, l, a, , A, , F, a, s, s, l, e, r, ;, , K, e, v, i, n, , J, , R, e, a, r, d, o, n, ;, , D, a, v, i, d, , S, , E, g, i, l, m, a, n

学術誌Accountability in research
年2018
PMID29258356

抄録

In 2001, DePuy, a wholly-owned subsidiary of Johnson & Johnson (J&J/DePuy), initiated a seeding study called the "Multi-center, Prospective, Clinical Evaluation of Pinnacle Acetabular Implants in Total Hip Arthroplasty" (PIN Study). J&J/DePuy designed this study to develop new business opportunities during the launch of their Pinnacle Hip System (PHS) and generate survivorship data for marketing. This article, the first review of a seeding trial for a medical device, examines internal company do

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。

↑